Ccr4 As Therapeutic Target For Cancer.

Patent No. EP2533047 (titled "Ccr4 As Therapeutic Target For Cancer.") was filed by Cancer Research Technology on Sep 18, 2008. The application was issued on May 11, 2016.

Patent Family

Statuses, jurisdictions and citation links are shared on request.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
APTARION BIOTECH AG	Feb 13, 2017	BOHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Jan 4, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jan 4, 2018
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Dec 22, 2017
Termination of the opposition proceedings with maintenance of patent
Sep 21, 2017
(Electronic) Receipt
Sep 21, 2017
Advice of delivery
Sep 21, 2017
Letter accompanying subsequently filed items
Sep 12, 2017
Acknowledgement of a document
Sep 12, 2017
Decision to discontinue the opposition proceedings
Aug 2, 2017
Brief communication - Opposition proceedings
Aug 1, 2017
Brief communication - Opposition proceedings
Jul 31, 2017
(Electronic) Receipt
Jul 31, 2017
Any annexes (other than citation) to an opposition letter
Jul 31, 2017
Letter accompanying subsequently filed items
Jul 25, 2017
(Electronic) Receipt
Jul 25, 2017
Letter accompanying subsequently filed items
Jul 25, 2017
Withdrawal of an opposition
Mar 22, 2017
Communication of a notice of opposition and request to file observations
Mar 22, 2017
Notice of further oppositions to opponent(s)
Feb 28, 2017
Communication of a notice of opposition - first information to patent proprietor
Feb 13, 2017
Letter accompanying subsequently filed items
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Non-patent literature cited during the opposition procedure
Feb 13, 2017
Notice of opposition
Feb 13, 2017
Notice of opposition
Feb 13, 2017
Patent document cited during the opposition procedure
Feb 13, 2017
Patent document cited during the opposition procedure
Feb 13, 2017
Patent document cited during the opposition procedure
Feb 13, 2017
Patent document cited during the opposition procedure
Feb 13, 2017
Patent document cited during the opposition procedure
Feb 13, 2017
Payment of fees and costs
May 12, 2016
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Apr 14, 2016
Decision to grant a European patent
Apr 6, 2016
Communication to designated inventor
Apr 6, 2016
Communication to designated inventor
Apr 6, 2016
Communication to designated inventor
Apr 5, 2016
Communication of the registration of a transfer or change of name and/or address
Apr 4, 2016
Decision to allow further processing
Mar 21, 2016
(Electronic) Receipt
Mar 21, 2016
Filing of the translations of the claims
Mar 21, 2016
French translation of claims
Mar 21, 2016
German translation of the claims
Mar 21, 2016
Letter accompanying subsequently filed items
Jan 12, 2016
Application deemed to be withdrawn ( translations of claims/payment missing)
Sep 17, 2015
Payment of fees and costs
Sep 17, 2015
Payment of fees and costs
Jul 13, 2015
Bibliographic data of the European patent application
Jul 13, 2015
Communication about intention to grant a European patent
Jul 13, 2015
Text intended for grant
Jul 8, 2015
Decision to allow further processing
Jun 29, 2015
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Jun 26, 2015
(Electronic) Receipt
Jun 26, 2015
Amended description with annotations
Jun 26, 2015
Description
Jun 26, 2015
Letter accompanying subsequently filed items
Jun 26, 2015
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Apr 21, 2015
Application deemed to be withdrawn ( translations of claims/payment missing)
Nov 4, 2014
Bibliographic data of the European patent application
Nov 4, 2014
Communication about intention to grant a European patent
Nov 4, 2014
Intention to grant (signatures)
Nov 4, 2014
Text intended for grant
Sep 17, 2014
Payment of fees and costs
Sep 17, 2014
Payment of fees and costs
Aug 5, 2014
(Electronic) Receipt
Aug 5, 2014
Amended description with annotations
Aug 5, 2014
Description
Aug 5, 2014
Letter accompanying subsequently filed items
Aug 5, 2014
Reply to communication from the Examining Division
Jul 14, 2014
Annex to the communication
Jul 14, 2014
Communication from the Examining Division
Mar 27, 2014
(Electronic) Receipt
Mar 27, 2014
Amended claims with annotations
Mar 27, 2014
Claims
Mar 27, 2014
Letter accompanying subsequently filed items
Mar 27, 2014
Non-patent literature cited during the examination procedure
Mar 27, 2014
Non-patent literature cited during the examination procedure
Mar 27, 2014
Reply to communication from the Examining Division
Jan 22, 2014
Annex to the communication
Jan 22, 2014
Communication from the Examining Division
Sep 26, 2013
Payment of fees and costs
Sep 26, 2013
Payment of fees and costs
May 29, 2013
(Electronic) Receipt
May 29, 2013
Amended claims filed after receipt of (European) search report
May 29, 2013
Amended claims with annotations
May 29, 2013
Amendments received before examination
May 29, 2013
Letter accompanying subsequently filed items
May 29, 2013
Non-patent literature cited during the examination procedure
May 29, 2013
Non-patent literature cited during the examination procedure
Dec 17, 2012
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Nov 14, 2012
Communication to designated inventor
Nov 14, 2012
Communication to designated inventor
Nov 14, 2012
Notification of forthcoming publication
Oct 31, 2012
Refund of fees
Oct 22, 2012
Designation of inventor
Oct 22, 2012
Letter concerning the inventor
Oct 9, 2012
Communication regarding the transmission of the European search report
Oct 9, 2012
European search opinion
Oct 9, 2012
European search report
Sep 20, 2012
Deficiency in designation of inventor
Sep 3, 2012
Abstract
Sep 3, 2012
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Sep 3, 2012
Amended claims with annotations
Sep 3, 2012
Annex
Sep 3, 2012
Claims
Sep 3, 2012
Converted Sequence Listing
Sep 3, 2012
Description
Sep 3, 2012
Drawings
Sep 3, 2012
Matter concerning the application
Sep 3, 2012
Request for grant of a European patent (divisional application)
Apr 21, 2009
Priority document (electronically transmitted)

EP2533047

CANCER RESEARCH TECHNOLOGY

Application Number: EP12182790A
Filing Date: Sep 18, 2008
Status: Opposition Procedure Closed
Publication Date: May 11, 2016
External Links: Slate, Register , Google Patents

IP Verse

Ccr4 As Therapeutic Target For Cancer.

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2533047